92 related articles for article (PubMed ID: 9530044)
1. Mammographic screening in women more than 64 years old: a comparison of 1- and 2-year intervals.
Field LR; Wilson TE; Strawderman M; Gabriel H; Helvie MA
AJR Am J Roentgenol; 1998 Apr; 170(4):961-5. PubMed ID: 9530044
[TBL] [Abstract][Full Text] [Related]
2. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
[TBL] [Abstract][Full Text] [Related]
3. Outcome analysis for women undergoing annual versus biennial screening mammography: a review of 24,211 examinations.
Hunt KA; Rosen EL; Sickles EA
AJR Am J Roentgenol; 1999 Aug; 173(2):285-9. PubMed ID: 10430120
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer in women 65-74 years old: earlier detection by mammographic screening.
Gabriel H; Wilson TE; Helvie MA
AJR Am J Roentgenol; 1997 Jan; 168(1):23-7. PubMed ID: 8976913
[TBL] [Abstract][Full Text] [Related]
5. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
6. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
7. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
8. Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ.
Carlson KL; Helvie MA; Roubidoux MA; Kleer CG; Oberman HA; Wilson TE; Pollak EW; Rochester AB
AJR Am J Roentgenol; 1999 Feb; 172(2):313-7. PubMed ID: 9930774
[TBL] [Abstract][Full Text] [Related]
9. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
[TBL] [Abstract][Full Text] [Related]
10. Mammography in 40-year-old women: what difference does it make? The potential impact of the U.S. Preventative Services Task Force (USPSTF) mammography guidelines.
Shen N; Hammonds LS; Madsen D; Dale P
Ann Surg Oncol; 2011 Oct; 18(11):3066-71. PubMed ID: 21863364
[TBL] [Abstract][Full Text] [Related]
11. Clinical and self breast examination remain important in the era of modern screening.
Ma I; Dueck A; Gray R; Wasif N; Giurescu M; Lorans R; Pizzitola V; Pockaj B
Ann Surg Oncol; 2012 May; 19(5):1484-90. PubMed ID: 22160521
[TBL] [Abstract][Full Text] [Related]
12. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
[TBL] [Abstract][Full Text] [Related]
13. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of breast cancers diagnosed in and outside of the large scale mammography program of the Ariana area of Tunisia].
Zeghal D; Mahjoub S; Zakraoui MA; Zouari F
Tunis Med; 2009 Jul; 87(7):450-3. PubMed ID: 20063678
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
16. Annual Screening Mammography Associated With Lower Stage Breast Cancer Compared With Biennial Screening.
Moorman SEH; Pujara AC; Sakala MD; Neal CH; Maturen KE; Swartz L; Egloff H; Helvie MA
AJR Am J Roentgenol; 2021 Jul; 217(1):40-47. PubMed ID: 33955776
[No Abstract] [Full Text] [Related]
17. Management of bilateral breast carcinoma: long-term results.
Goksel HA; Yagmurdur MC; Karakayali H; Moray G; Demirhan B; Isiklar I; Bilgin N; Haberal M
Int Surg; 2004; 89(3):166-71. PubMed ID: 15521255
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the contralateral breast in patients with ipsilateral breast carcinoma: the role of mammography.
Muttarak M; Pojchamarnwiputh S; Padungchaichote W; Chaiwun B
Singapore Med J; 2002 May; 43(5):229-33. PubMed ID: 12188073
[TBL] [Abstract][Full Text] [Related]
19. Impact of a mailed intervention on annual mammography and physician breast examinations among women at high risk of breast cancer.
Richardson JL; Mondrus GT; Danley K; Deapen D; Mack T
Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):71-6. PubMed ID: 8770470
[TBL] [Abstract][Full Text] [Related]
20. Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy.
Yang WT; Dryden MJ; Gwyn K; Whitman GJ; Theriault R
Radiology; 2006 Apr; 239(1):52-60. PubMed ID: 16484353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
